Precision Psychiatry Market Size, Global Trends, Share And Forecast to 2033

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Precision Psychiatry Market Size Analysis

Global Precision Psychiatry Market Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Products
  1. By Value
3. Services
  1. By Value
By Sample Type
1. Introduction
  1. Sample Type By Value
2. Blood-Based
  1. By Value
3. Non-Blood-Based
  1. By Value
By Biomarker Type
1. Introduction
  1. Biomarker Type By Value
2. Genetic Biomarker
  1. By Value
3. Protein Biomarker
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Sequencing (NGS and Traditional Sequencing)
  1. By Value
3. Polymerase Chain Reaction (RT-PCR and dPCR)
  1. By Value
4. Microarray
  1. By Value
5. Immunoassay
  1. By Value
6. Liquid Chromatography/Mass Spectrometry
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Alzheimer’s Disease
  1. By Value
3. Parkinson’s Disease
  1. By Value
4. Autism
  1. By Value
5. Depression
  1. By Value
6. Bipolar Disease
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Academic and Research Institutions
  1. By Value
3. Hospitals and Diagnostic Laboratories
  1. By Value

North America Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Products
  1. By Value
3. Services
  1. By Value
By Sample Type
1. Introduction
  1. Sample Type By Value
2. Blood-Based
  1. By Value
3. Non-Blood-Based
  1. By Value
By Biomarker Type
1. Introduction
  1. Biomarker Type By Value
2. Genetic Biomarker
  1. By Value
3. Protein Biomarker
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Sequencing (NGS and Traditional Sequencing)
  1. By Value
3. Polymerase Chain Reaction (RT-PCR and dPCR)
  1. By Value
4. Microarray
  1. By Value
5. Immunoassay
  1. By Value
6. Liquid Chromatography/Mass Spectrometry
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Alzheimer’s Disease
  1. By Value
3. Parkinson’s Disease
  1. By Value
4. Autism
  1. By Value
5. Depression
  1. By Value
6. Bipolar Disease
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Academic and Research Institutions
  1. By Value
3. Hospitals and Diagnostic Laboratories
  1. By Value
U.S.
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Products
    1. By Value
  3. Services
    1. By Value
2. By Sample Type
  1. Introduction
    1. Sample Type By Value
  2. Blood-Based
    1. By Value
  3. Non-Blood-Based
    1. By Value
3. By Biomarker Type
  1. Introduction
    1. Biomarker Type By Value
  2. Genetic Biomarker
    1. By Value
  3. Protein Biomarker
    1. By Value
4. By Technology
  1. Introduction
    1. Technology By Value
  2. Sequencing (NGS and Traditional Sequencing)
    1. By Value
  3. Polymerase Chain Reaction (RT-PCR and dPCR)
    1. By Value
  4. Microarray
    1. By Value
  5. Immunoassay
    1. By Value
  6. Liquid Chromatography/Mass Spectrometry
    1. By Value
5. By Application
  1. Introduction
    1. Application By Value
  2. Alzheimer’s Disease
    1. By Value
  3. Parkinson’s Disease
    1. By Value
  4. Autism
    1. By Value
  5. Depression
    1. By Value
  6. Bipolar Disease
    1. By Value
6. By End User
  1. Introduction
    1. End User By Value
  2. Academic and Research Institutions
    1. By Value
  3. Hospitals and Diagnostic Laboratories
    1. By Value
Canada

Europe Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Products
  1. By Value
3. Services
  1. By Value
By Sample Type
1. Introduction
  1. Sample Type By Value
2. Blood-Based
  1. By Value
3. Non-Blood-Based
  1. By Value
By Biomarker Type
1. Introduction
  1. Biomarker Type By Value
2. Genetic Biomarker
  1. By Value
3. Protein Biomarker
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Sequencing (NGS and Traditional Sequencing)
  1. By Value
3. Polymerase Chain Reaction (RT-PCR and dPCR)
  1. By Value
4. Microarray
  1. By Value
5. Immunoassay
  1. By Value
6. Liquid Chromatography/Mass Spectrometry
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Alzheimer’s Disease
  1. By Value
3. Parkinson’s Disease
  1. By Value
4. Autism
  1. By Value
5. Depression
  1. By Value
6. Bipolar Disease
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Academic and Research Institutions
  1. By Value
3. Hospitals and Diagnostic Laboratories
  1. By Value
U.K.
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Products
    1. By Value
  3. Services
    1. By Value
2. By Sample Type
  1. Introduction
    1. Sample Type By Value
  2. Blood-Based
    1. By Value
  3. Non-Blood-Based
    1. By Value
3. By Biomarker Type
  1. Introduction
    1. Biomarker Type By Value
  2. Genetic Biomarker
    1. By Value
  3. Protein Biomarker
    1. By Value
4. By Technology
  1. Introduction
    1. Technology By Value
  2. Sequencing (NGS and Traditional Sequencing)
    1. By Value
  3. Polymerase Chain Reaction (RT-PCR and dPCR)
    1. By Value
  4. Microarray
    1. By Value
  5. Immunoassay
    1. By Value
  6. Liquid Chromatography/Mass Spectrometry
    1. By Value
5. By Application
  1. Introduction
    1. Application By Value
  2. Alzheimer’s Disease
    1. By Value
  3. Parkinson’s Disease
    1. By Value
  4. Autism
    1. By Value
  5. Depression
    1. By Value
  6. Bipolar Disease
    1. By Value
6. By End User
  1. Introduction
    1. End User By Value
  2. Academic and Research Institutions
    1. By Value
  3. Hospitals and Diagnostic Laboratories
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Products
  1. By Value
3. Services
  1. By Value
By Sample Type
1. Introduction
  1. Sample Type By Value
2. Blood-Based
  1. By Value
3. Non-Blood-Based
  1. By Value
By Biomarker Type
1. Introduction
  1. Biomarker Type By Value
2. Genetic Biomarker
  1. By Value
3. Protein Biomarker
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Sequencing (NGS and Traditional Sequencing)
  1. By Value
3. Polymerase Chain Reaction (RT-PCR and dPCR)
  1. By Value
4. Microarray
  1. By Value
5. Immunoassay
  1. By Value
6. Liquid Chromatography/Mass Spectrometry
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Alzheimer’s Disease
  1. By Value
3. Parkinson’s Disease
  1. By Value
4. Autism
  1. By Value
5. Depression
  1. By Value
6. Bipolar Disease
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Academic and Research Institutions
  1. By Value
3. Hospitals and Diagnostic Laboratories
  1. By Value
China
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Products
    1. By Value
  3. Services
    1. By Value
2. By Sample Type
  1. Introduction
    1. Sample Type By Value
  2. Blood-Based
    1. By Value
  3. Non-Blood-Based
    1. By Value
3. By Biomarker Type
  1. Introduction
    1. Biomarker Type By Value
  2. Genetic Biomarker
    1. By Value
  3. Protein Biomarker
    1. By Value
4. By Technology
  1. Introduction
    1. Technology By Value
  2. Sequencing (NGS and Traditional Sequencing)
    1. By Value
  3. Polymerase Chain Reaction (RT-PCR and dPCR)
    1. By Value
  4. Microarray
    1. By Value
  5. Immunoassay
    1. By Value
  6. Liquid Chromatography/Mass Spectrometry
    1. By Value
5. By Application
  1. Introduction
    1. Application By Value
  2. Alzheimer’s Disease
    1. By Value
  3. Parkinson’s Disease
    1. By Value
  4. Autism
    1. By Value
  5. Depression
    1. By Value
  6. Bipolar Disease
    1. By Value
6. By End User
  1. Introduction
    1. End User By Value
  2. Academic and Research Institutions
    1. By Value
  3. Hospitals and Diagnostic Laboratories
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Products
  1. By Value
3. Services
  1. By Value
By Sample Type
1. Introduction
  1. Sample Type By Value
2. Blood-Based
  1. By Value
3. Non-Blood-Based
  1. By Value
By Biomarker Type
1. Introduction
  1. Biomarker Type By Value
2. Genetic Biomarker
  1. By Value
3. Protein Biomarker
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Sequencing (NGS and Traditional Sequencing)
  1. By Value
3. Polymerase Chain Reaction (RT-PCR and dPCR)
  1. By Value
4. Microarray
  1. By Value
5. Immunoassay
  1. By Value
6. Liquid Chromatography/Mass Spectrometry
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Alzheimer’s Disease
  1. By Value
3. Parkinson’s Disease
  1. By Value
4. Autism
  1. By Value
5. Depression
  1. By Value
6. Bipolar Disease
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Academic and Research Institutions
  1. By Value
3. Hospitals and Diagnostic Laboratories
  1. By Value
UAE
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Products
    1. By Value
  3. Services
    1. By Value
2. By Sample Type
  1. Introduction
    1. Sample Type By Value
  2. Blood-Based
    1. By Value
  3. Non-Blood-Based
    1. By Value
3. By Biomarker Type
  1. Introduction
    1. Biomarker Type By Value
  2. Genetic Biomarker
    1. By Value
  3. Protein Biomarker
    1. By Value
4. By Technology
  1. Introduction
    1. Technology By Value
  2. Sequencing (NGS and Traditional Sequencing)
    1. By Value
  3. Polymerase Chain Reaction (RT-PCR and dPCR)
    1. By Value
  4. Microarray
    1. By Value
  5. Immunoassay
    1. By Value
  6. Liquid Chromatography/Mass Spectrometry
    1. By Value
5. By Application
  1. Introduction
    1. Application By Value
  2. Alzheimer’s Disease
    1. By Value
  3. Parkinson’s Disease
    1. By Value
  4. Autism
    1. By Value
  5. Depression
    1. By Value
  6. Bipolar Disease
    1. By Value
6. By End User
  1. Introduction
    1. End User By Value
  2. Academic and Research Institutions
    1. By Value
  3. Hospitals and Diagnostic Laboratories
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Products
  1. By Value
3. Services
  1. By Value
By Sample Type
1. Introduction
  1. Sample Type By Value
2. Blood-Based
  1. By Value
3. Non-Blood-Based
  1. By Value
By Biomarker Type
1. Introduction
  1. Biomarker Type By Value
2. Genetic Biomarker
  1. By Value
3. Protein Biomarker
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Sequencing (NGS and Traditional Sequencing)
  1. By Value
3. Polymerase Chain Reaction (RT-PCR and dPCR)
  1. By Value
4. Microarray
  1. By Value
5. Immunoassay
  1. By Value
6. Liquid Chromatography/Mass Spectrometry
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Alzheimer’s Disease
  1. By Value
3. Parkinson’s Disease
  1. By Value
4. Autism
  1. By Value
5. Depression
  1. By Value
6. Bipolar Disease
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Academic and Research Institutions
  1. By Value
3. Hospitals and Diagnostic Laboratories
  1. By Value
Brazil
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Products
    1. By Value
  3. Services
    1. By Value
2. By Sample Type
  1. Introduction
    1. Sample Type By Value
  2. Blood-Based
    1. By Value
  3. Non-Blood-Based
    1. By Value
3. By Biomarker Type
  1. Introduction
    1. Biomarker Type By Value
  2. Genetic Biomarker
    1. By Value
  3. Protein Biomarker
    1. By Value
4. By Technology
  1. Introduction
    1. Technology By Value
  2. Sequencing (NGS and Traditional Sequencing)
    1. By Value
  3. Polymerase Chain Reaction (RT-PCR and dPCR)
    1. By Value
  4. Microarray
    1. By Value
  5. Immunoassay
    1. By Value
  6. Liquid Chromatography/Mass Spectrometry
    1. By Value
5. By Application
  1. Introduction
    1. Application By Value
  2. Alzheimer’s Disease
    1. By Value
  3. Parkinson’s Disease
    1. By Value
  4. Autism
    1. By Value
  5. Depression
    1. By Value
  6. Bipolar Disease
    1. By Value
6. By End User
  1. Introduction
    1. End User By Value
  2. Academic and Research Institutions
    1. By Value
  3. Hospitals and Diagnostic Laboratories
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Precision Psychiatry Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Illumina, Inc
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
F. Hoffmann-La Roche Ltd
Bio-Rad Laboratories, Inc
QIAGEN N.V.
Quest Diagnostics Incorporated
ARUP Laboratories
Invitae Corporation
OPKO Health, Inc
Laboratory Corporation of America Holdings
Centogene N.V.
Thermo Fisher Scientific Inc
Myriad Genetics, Inc
Konica Minolta, Inc
Fulgent Genetics
Prevention Genetics

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment